封面
市場調查報告書
商品編碼
2129072

新生牛血清市場:按類型、應用、最終用戶、國家和地區分類-全球產業分析、市場規模、市場佔有率及2026-2033年預測

Newborn Calf Serum Market, By Type, By Application, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033

出版日期: | 出版商: AnalystView Market Insights | 英文 400 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2025 年,新生牛血清市場規模將達到 2.903 億美元,從 2026 年到 2033 年,年複合成長率將達到 6.9%。

新生牛血清(NBCS)是指從新生牛採集的血清,用作細胞培養添加劑。該市場不僅包括常規血清,還包括一些特殊類型,例如用於科研和生物製程的活性碳處理血清和熱去活化血清。其重要性在於富含營養物質,包括蛋白質、生長因子、脂質、荷爾蒙和其他有助於維持細胞培養的成分。市場需求更受性能和品質而非消費量驅動。根據Serana 2025年產品目錄,新生牛血清有500毫升和1000毫升兩種規格,保存期限為5年。因此,加強規格控制對於產品能否被市場接受變得越來越重要。

新生牛血清市場-市場動態

更嚴格的批次認證和可追溯性要求

由於對合格血清鑑定的需求日益成長,對標準化新生牛血清 (NBCS) 的需求也隨之增加。這是因為實驗室希望在不影響現有流程的前提下,實現細胞培養投入物的可重複性。批次客製化是透過過濾、可追溯性、無菌性、黴漿菌、病毒、內毒素和生化檢測來實現的,從而使用戶能夠將血清特性與其自身高度敏感的流程和生產過程關聯起來。根據 Serana 2025 產品目錄,新生牛血清需經過 0.2 μm 無菌過濾,並檢測蛋白質、白蛋白、血紅素、黴漿菌、病毒和無菌性。對如此多種特性的檢測可降低批次間差異所造成的不確定性,並有助於血清合格。因此,除了性能之外,品質文件也正成為另一項採購標準。

新生牛血清市場-市場區隔分析:

全球新生牛血清市場按類型、應用、最終用戶和地區進行細分。

就類型而言,選擇取決於最終用途所需的生化控制等級。因此,標準(常規)血清是最常見的類型,它是細胞培養中蛋白質和生長因子的天然來源。如果需要抑制補體活性,根據美國藥典(USP)指南,建議使用在56°C或更高溫度下處理30分鐘的熱去活化血清。另一方面,當需要降低荷爾蒙濃度時,尤其是在內分泌研究等特定應用中,則使用活性碳處理血清。 Serana 2025年的產品目錄包括500毫升和1000毫升規格的新生牛血清和γ射線輻照產品。客製化正成為該市場供應商的關鍵差異化因素。

從應用角度來看,特定用途的需求主要集中在細胞研究和生物製藥製程中,血清的表現會影響細胞黏附、增殖、分化和檢測結果的重複性。在診斷領域,血清被用作受控生物試劑;而在疫苗和藥物研發項目中,特定的細胞培養需要在特定條件下進行。體外受精是應用特定用途的一個例子,在生殖醫學實驗室中,受控培養基和檢驗的成分至關重要。 2025 年 Serana 產品目錄顯示,新生牛血清經過黴漿菌、病毒、無菌性、蛋白質、白蛋白和血紅蛋白的檢測,這反映了實驗室環境中嚴格的品質控制。

新生牛血清市場-區域分析

北美地區憑藉其先進的研究、診斷、疫苗和生物製藥基礎設施,以及眾多需要使用血清的工作流程,仍然是重要的市場。例如,根據美國農業部的報告,預計到2025年,美國的牛數量將達到8,670萬牛。該地區已具備生物材料來源的基礎設施,不僅能夠採集血清,還能維持滿足溯源、無菌過濾、病毒檢測和特殊處理等要求的品管系統。因此,能夠提供批次穩定且分析證書的血清公司在該地區更受歡迎。由此可見,北美地區的血清需求以規格主導,並基於細胞培養的性能檢驗進行選擇。

隨著中國及其他市場生物製藥生產和研發能力的不斷提升,亞太地區正崛起為關鍵市場。 2025年6月3日,藥明生物在成都啟動了一座微生物生產設施的興建。該設施將配備15,000公升發酵罐,年產能可達80至110批原料藥和超過1,000萬管瓶製劑。這顯示該地區生物製藥生產活動蓬勃發展,並蘊藏著對細胞培養用血清的巨大需求。供應商正持續開發品管可控的血清和培養基產品線。

目錄

第1章 新生牛血清市場概覽

  • 分析範圍
  • 市場估算期

第2章執行摘要

  • 市場區隔
  • 競爭考察

第3章 新生牛血清主要市場趨勢

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 未來市場趨勢

第4章:新生牛血清產業分析

  • PEST分析
  • 波特五力分析
  • 市場成長前景展望圖
  • 管理體制分析

第5章:新生牛血清市場:地緣政治緊張局勢加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章:新生牛血清市場現狀

  • 2025年新生牛血清市佔分析
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

第7章:牛牛血清市場:依類型分類

  • 概述
    • 基於細分市場的市場佔有率分析:按類型
    • 活性碳去除精華液
    • 標準/正常血清
    • 熱去活化血清

第8章 新生牛血清市場:依應用領域分類

  • 概述
    • 基於細分市場的市場佔有率分析:按應用領域
    • 診斷和生物製藥製造
    • 藥物發現
    • 疫苗生產
    • 體外受精
    • 基於細胞的研究
    • 其他

第9章:新生牛血清市場:依最終用戶分類

  • 概述
    • 基於細分市場的市場佔有率分析:按最終用戶分類
    • 合約研究組織(CRO)
    • 製藥和生物技術公司
    • 學術和研究機構
    • 其他

第10章:新生牛血清市場:依地區分類

  • 介紹
  • 北美洲
    • 概述
    • 主要製造商:北美
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 主要製造商:歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 丹麥
    • 其他歐洲國家
  • 亞太地區
    • 概述
    • 主要製造商:亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 台灣
    • 越南
    • 其他亞太國家
  • 拉丁美洲
    • 概述
    • 主要製造商:拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他拉丁美洲國家
  • 中東和非洲
    • 概述
    • 主要生產商:中東和非洲
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 伊朗
    • 卡達
    • 其他中東和非洲國家

第11章:主要供應商分析:新生牛血清產業

  • 競爭基準
    • 競爭對手儀錶板
    • 競爭定位
  • 公司簡介
    • HiMedia Laboratories
    • Thermo Fisher Scientific Inc.
    • Sartorius AG
    • Merck KGaA
    • Corning Inc.
    • Atlas Biologicals, Inc.
    • TCS Biosciences Ltd.
    • Bovogen Biologicals Pty Ltd.
    • Capricorn Scientific
    • PAN-Biotech GmbH
    • GE Healthcare
    • Serana
    • Biowest
    • RMBIO(Rocky Mountain Biologicals)
    • Zhejiang Tianhang Biotechnology
    • Others

第12章:AnalystView 的全景視圖

簡介目錄
Product Code: ANV7330

Newborn Calf Serum Market size was valued at US$ 290.3 Million in 2025, expanding at a CAGR of 6.9% from 2026 to 2033.

Newborn calf serum (NBCS) refers to serum derived from newborn calves and is used as a cell culture supplement. The market involves both conventional and special types of serum, such as charcoal-stripped and heat-inactivated forms, available for research and bioprocessing applications. It derives its significance from the availability of nutrients, including proteins, growth factors, lipids, hormones, and other components that help maintain cell culture. Its demand does not depend much on its consumption but on its performance and quality. According to the 2025 Serana catalog, newborn calf serum is available in 500 mL and 1,000 mL bottles with a five-year shelf life. Therefore, increased specification control is becoming more important in determining the acceptance of products.

Newborn Calf Serum Market- Market Dynamics

Tighter Lot Qualification and Traceability Requirements

Customized serum qualification increases the need for standardized NBCS, as laboratories require reproducibility of cell culture inputs without affecting current procedures. Customization of batches is done through filtration, traceability, sterility, mycoplasma, virus, endotoxin, and biochemical tests, enabling users to correlate serum properties with their sensitive procedures or manufacturing. The Serana 2025 catalog indicates that newborn calf serum will have 0.2 μm sterile filtration and testing for protein, albumin, hemoglobin, mycoplasma, virus, and sterility properties. This kind of testing on multiple attributes lowers uncertainties in batch variations and assists in serum qualification. Therefore, documentation of quality is becoming another purchase criterion along with performance.

Newborn Calf Serum Market- Segmentation Analysis:

The Global Newborn Calf Serum Market is segmented on the basis of Type, Application, End User, and Region.

By type, type selection is based on the level of biochemical control needed for the end application. Thus, standard or regular serum is the most common type, as it provides a natural source of proteins and growth factors for cell culture. Serum that has been heat-inactivated is recommended when complement activity may need to be inhibited, according to USP guidelines, with treatment at more than 56 degrees Celsius for thirty minutes. Meanwhile, a charcoal-stripped type is used when reduced levels of hormones are indicated, with specific applications in endocrine research. The 2025 catalog of Serana lists newborn calf serum and gamma-irradiated options in 500 mL and 1,000 mL sizes. Personalization is becoming a key feature that differentiates suppliers in this market.

By applications, application-specific demands are focused on cell-based studies and biopharmaceutical processes, wherein the performance of serum affects cell adhesion, growth, differentiation, and the ability to reproduce assays. In diagnostics, serum is used as a controlled biological reagent, whereas, in vaccines and drug discovery programs, certain cell cultures need to be maintained under specific conditions. In vitro fertilization is an example of an application-specific use, wherein reproductive laboratories emphasize controlled media and validated components. In the Serana catalog of 2025, newborn calf serum is tested for mycoplasma, virus, sterility, protein, albumin, and hemoglobin, showing how thorough the specifications can be in a laboratory setting.

Newborn Calf Serum Market- Geographical Insights

North America remains an important market due to its advanced research, diagnostics, vaccine, and biopharmaceutical infrastructure, with several serum-consuming workflows. For instance, the number of cattle and calves in the United States entering 2025 was 86.7 million, according to the USDA report. This region already possesses an infrastructure of biological material sources, allowing for serum collection as well as maintaining a quality-controlled system with demands for traceable origin, sterile filtration, viral testing, and special treatment. Thus, the region favors companies able to provide consistent lots and certificates of analysis. This results in the fact that serum demand in North America is specification-driven since the choice is made based on the validation of cell culture performance.

Asia Pacific is emerging as an important market due to increased biopharmaceutical production and research capacities in China and other markets. On June 3, 2025, WuXi Biologics started building the Chengdu microbial manufacturing facility, which includes a 15,000-liter fermenter and annual production of 80 to 110 drug substance batches, as well as more than 10 million vials of drug products per year. This demonstrates how much biologics manufacturing activity takes place in this region and can create demand for serum for cell culture cultivation. Suppliers continue to develop quality-controlled portfolios of sera and media.

Newborn Calf Serum Market- Competitive Landscape:

The competition in the life science supplies and serum manufacturing industries is fragmented, and differentiation is based on origin, processing, testing, customization, and documentation. Competitors in the market include Thermo Fisher Scientific, Merck, Bio-Techne, Sartorius, Biosera, Bovogen, Capricorn Scientific, and SeraPrime. These companies compete in terms of portfolios of serums, filters, heat treatment, irradiation, documentation, and technical services. The Serana catalog for 2025 provides information about newborn calf serum in 500 mL and 1,000 mL volumes and states a five-year shelf life. This clearly shows the importance of having standard specifications and stability in serum manufacturing industries.

Recent Developments:

In March 2025, Capricorn Scientific increased cGMP standards by utilizing water-for-injection quality water in cell culture processes. This further emphasizes control in manufacturing as well as increased production of quality serum and media for bioprocesses.

In April 2025, Capricorn Scientific and Florabio partnered to provide animal-free cell culture media with high-yield capabilities for biotechnology and vaccine production. This enhances serum-free options and increases competition against animal-derived sera in the market.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NEWBORN CALF SERUM MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • HiMedia Laboratories
  • Thermo Fisher Scientific Inc.
  • Sartorius AG
  • Merck KGaA
  • Corning Inc.
  • Atlas Biologicals, Inc.
  • TCS Biosciences Ltd.
  • Bovogen Biologicals Pty Ltd.
  • Capricorn Scientific
  • PAN-Biotech GmbH
  • GE Healthcare
  • Serana
  • Biowest
  • RMBIO (Rocky Mountain Biologicals)
  • Zhejiang Tianhang Biotechnology
  • Others

GLOBAL NEWBORN CALF SERUM MARKET, BY TYPE- MARKET ANALYSIS, 2020 - 2033

  • Charcoal Stripped Serum
  • Standard/Regular Serum
  • Heat Inactivated Serum

GLOBAL NEWBORN CALF SERUM MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

  • Diagnostics and biopharmaceutical manufacturing
  • Drugs discovery
  • Vaccine production
  • In-vitro fertilization
  • Cell-based research
  • Others

GLOBAL NEWBORN CALF SERUM MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033

  • Contract Research Organizations (CRO)
  • Pharmaceutical & biotechnology companies
  • Academic and research organizations
  • Others

GLOBAL NEWBORN CALF SERUM MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Denmark
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Taiwan
  • Vietnam
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Iran
  • Qatar
  • Rest of MEA

Table of Contents

1. Newborn Calf Serum Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Newborn Calf Serum Market Snippet by Type
    • 2.1.2. Newborn Calf Serum Market Snippet by Application
    • 2.1.3. Newborn Calf Serum Market Snippet by End User
    • 2.1.4. Newborn Calf Serum Market Snippet by Country
    • 2.1.5. Newborn Calf Serum Market Snippet by Region
  • 2.2. Competitive Insights

3. Newborn Calf Serum Key Market Trends

  • 3.1. Newborn Calf Serum Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Newborn Calf Serum Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Newborn Calf Serum Market Opportunities
  • 3.4. Newborn Calf Serum Market Future Trends

4. Newborn Calf Serum Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Newborn Calf Serum Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Newborn Calf Serum Market Landscape

  • 6.1. Newborn Calf Serum Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Newborn Calf Serum Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2025 & 2033 (%)
    • 7.1.2. Charcoal Stripped Serum
    • 7.1.3. Standard/Regular Serum
    • 7.1.4. Heat Inactivated Serum

8. Newborn Calf Serum Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
    • 8.1.2. Diagnostics and biopharmaceutical manufacturing
    • 8.1.3. Drugs discovery
    • 8.1.4. Vaccine production
    • 8.1.5. In-vitro fertilization
    • 8.1.6. Cell-based research
    • 8.1.7. Others

9. Newborn Calf Serum Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
    • 9.1.2. Contract Research Organizations (CRO)
    • 9.1.3. Pharmaceutical & biotechnology companies
    • 9.1.4. Academic and research organizations
    • 9.1.5. Others

10. Newborn Calf Serum Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Newborn Calf Serum Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Newborn Calf Serum Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.16. Denmark
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.16.3. Denmark Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.3.16.4. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.16.5. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.17. Rest of Europe
      • 10.3.17.1. Overview
      • 10.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.17.3. Rest of the Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.3.17.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.17.5. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Newborn Calf Serum Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.15. Taiwan
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.15.3. Taiwan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.4.15.4. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.15.5. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.16. Vietnam
      • 10.4.16.1. Overview
      • 10.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.16.3. Vietnam Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.4.16.4. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.16.5. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.17. Rest of APAC
      • 10.4.17.1. Overview
      • 10.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.17.3. Rest of APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.4.17.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.17.5. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Newborn Calf Serum Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Newborn Calf Serum Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.13. Iran
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.13.3. Iran Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.6.13.4. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.13.5. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.14. Qatar
      • 10.6.14.1. Overview
      • 10.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.14.3. Qatar Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.6.14.4. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.14.5. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.15. Rest of MEA
      • 10.6.15.1. Overview
      • 10.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.15.3. Rest of MEA Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.6.15.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.15.5. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)

11. Key Vendor Analysis- Newborn Calf Serum Industry

  • 11.1. Competitive Benchmarking
    • 11.1.1. Competitive Dashboard
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. HiMedia Laboratories
    • 11.2.2. Thermo Fisher Scientific Inc.
    • 11.2.3. Sartorius AG
    • 11.2.4. Merck KGaA
    • 11.2.5. Corning Inc.
    • 11.2.6. Atlas Biologicals, Inc.
    • 11.2.7. TCS Biosciences Ltd.
    • 11.2.8. Bovogen Biologicals Pty Ltd.
    • 11.2.9. Capricorn Scientific
    • 11.2.10. PAN-Biotech GmbH
    • 11.2.11. GE Healthcare
    • 11.2.12. Serana
    • 11.2.13. Biowest
    • 11.2.14. RMBIO (Rocky Mountain Biologicals)
    • 11.2.15. Zhejiang Tianhang Biotechnology
    • 11.2.16. Others

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us